ChatGPT picks 2 recession-proof stocks to buy in 2026
The post ChatGPT picks 2 recession-proof stocks to buy in 2026 appeared on BitcoinEthereumNews.com.
Rising recession concerns in the United States are reshaping investor positioning in 2026, as slowing growth, persistent inflation, and geopolitical tensions weigh on the outlook. Major Wall Street institutions now estimate a 30% to 40% chance of a downturn over the next year, marking a shift from earlier soft-landing expectations as economic data show signs of strain. Indeed, markets are reacting to rising risks, with high oil prices and tight Federal Reserve policy threatening growth and increasing volatility. As recession concerns build, investors are shifting toward capital preservation, favoring stable, cash-generating companies. Against this backdrop, Finbold used OpenAI’s ChatGPT to identify two stocks to hedge against a downturn. Procter & Gamble (NYSE: PG) The first is Procter & Gamble (NYSE: PG), a global consumer staples giant whose product portfolio includes essential household items such as cleaning supplies, personal care products, and hygiene goods. According to ChatGPT, the company’s resilience stems from the non-discretionary nature of its offerings, which sustain demand even as consumers cut back on optional spending. Its scale and brand strength allow it to pass on higher costs through pricing, preserving margins in inflationary environments. This stability is reinforced by a decades-long track record of dividend growth, supported by consistent cash generation across economic cycles. At press time, PG stock was trading at $142, having gained less than 1% year to date. PG YTD stock price chart. Source: Finbold Johnson & Johnson (NYSE: JNJ) In the second spot, ChatGPT selected healthcare giant Johnson & Johnson (NYSE: JNJ). The company has, over the years, emerged as a diversified healthcare leader with exposure to pharmaceuticals, medical devices, and consumer health products. The AI model noted that demand for healthcare remains structurally inelastic, providing a steady revenue base regardless of macroeconomic conditions. At the same time, Johnson & Johnson’s diversified business…
Filed under: News - @ March 29, 2026 12:15 pm